Published in

Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 13(22), p. 1651-1660, 2021

DOI: 10.1080/14656566.2021.1942455

Links

Tools

Export citation

Search in Google Scholar

Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indication

Journal article published in 2021 by John Davis, Daisy Zamora, Mark Horowitz ORCID, Stefan Leucht
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO